The Ventana FOLR-2.1 assay was used to diagnose FRα-positive tumors by using a qualitative immunohistochemical assay, which detects moderate-to-strong membrane staining in at least 75% of tumor cells. This evidence concerns the gene FOLR1 and neoplasm.